FLUTE Cross-border Prostate Cancer Data Standard Guide
0.1.0 - ci-build
FLUTE Cross-border Prostate Cancer Data Standard Guide
0.1.0 - ci-build
FLUTE Cross-border Prostate Cancer Data Standard Guide, published by Flute Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/flute/ and changes regularly. See the Directory of published versions
| Draft as of 2025-11-05 |
Definitions for the InclusionCriterias logical model.
Guidance on how to interpret the contents of this table can be foundhere
| 0. InclusionCriterias | |
| Definition | Criteria for including men in cohorts based on clinical suspicion of prostate cancer. |
| Short | Inclusion Criteria for Prostate Cancer Cohorts |
| Control | 0..* |
| Is Modifier | false |
| Logical Model | Instances of this logical model are not marked to be the target of a Reference |
| 2. InclusionCriterias.psa | |
| Definition | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. |
| Short | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. |
| Control | 0..1 |
| Type | Quantity |
| 4. InclusionCriterias.dre | |
| Definition | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). |
| Short | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). |
| Control | 0..1 |
| Type | integer |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
Guidance on how to interpret the contents of this table can be foundhere
| 0. InclusionCriterias | |
| Definition | Criteria for including men in cohorts based on clinical suspicion of prostate cancer. |
| Short | Inclusion Criteria for Prostate Cancer Cohorts |
| Logical Model | Instances of this logical model are not marked to be the target of a Reference |
| 2. InclusionCriterias.psa | |
| Definition | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. |
| Short | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. |
| Control | 0..1 |
| Type | Quantity |
| 4. InclusionCriterias.dre | |
| Definition | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). |
| Short | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). |
| Control | 0..1 |
| Type | integer |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |
Guidance on how to interpret the contents of this table can be foundhere
| 0. InclusionCriterias | |
| Definition | Criteria for including men in cohorts based on clinical suspicion of prostate cancer. |
| Short | Inclusion Criteria for Prostate Cancer Cohorts |
| Control | 0..* |
| Is Modifier | false |
| Logical Model | Instances of this logical model are not marked to be the target of a Reference |
| 2. InclusionCriterias.psa | |
| Definition | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. |
| Short | Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml. |
| Control | 0..1 |
| Type | Quantity |
| 4. InclusionCriterias.dre | |
| Definition | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). |
| Short | Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious). |
| Control | 0..1 |
| Type | integer |
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension |